Water Island Capital LLC Aura Biosciences, Inc. Transaction History

Water Island Capital LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2024	BUY	$8.97 - $12.38 $26,013 - $35,902	2,900 Added 14.68%	22,650 $203,000
Q3 2023 Nov 14, 2023	BUY	$8.97 - $12.38 $26,013 - $35,902	2,900 Added 14.68%	22,650 $203,000
Q2 2023 Nov 14, 2024	SELL	$8.51 - $13.33 $33,325 - $52,200	-3,916 Reduced 16.55%	19,750 $243,000
Q2 2023 Aug 14, 2023	SELL	$8.51 - $13.33 $33,325 - $52,200	-3,916 Reduced 16.55%	19,750 $244,000
Q1 2023 Nov 14, 2024	BUY	$8.88 - $12.11 $1,474 - $2,010	166 Added 0.71%	23,666 $219,000
Q1 2023 May 25, 2023	BUY	$8.88 - $12.11 $1,474 - $2,010	166 Added 0.71%	23,666 $220,000
Q4 2022 Nov 14, 2024	BUY	$9.86 - $14.59 $231,710 - $342,865	23,500 New	23,500 $246,000
Q4 2022 Feb 14, 2023	BUY	$9.86 - $14.59 $126,208 - $186,752	12,800 Added 119.63%	23,500 $247,000
Q3 2022 Nov 14, 2022	SELL	$13.1 - $20.34 $50,317 - $78,125	-3,841 Reduced 26.41%	10,700 $194,000
Q2 2022 Aug 15, 2022	BUY	$12.37 - $21.86 $179,872 - $317,866	14,541 New	14,541 $206,000

37.6M

122K

38.5K

Ticker AURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,273,600
Market Cap $268M
Description
Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. It develops AU-011, a VDC candidate for the treatment of primary choroidal melanoma. It also develop...

Get notified when there are updates to the investment portfolio of Water Island Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Water Island Capital LLC with notifications on news.